Pharmaceutical

Cellusion shares pipeline update for eye disease stem cell therapy

Cellusion shares Phase I/II clinical development plans for its bullous keratopathy stem cell therapy CSL-001.

Jun 29, 2023 - 20:00
Cellusion shares pipeline update for eye disease stem cell therapy
Cellusion shares Phase I/II clinical development plans for its bullous keratopathy stem cell therapy CSL-001.
Read the original article

Tags:

Previous Article

Pfizer’s Ngenla finally secures FDA approval following a rocky road to market

Next Article

The promising role of GLP-1RAs in NASH

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT+: The prices of 8 drugs were hiked without proof o...

Dec 11, 2023

Respiratory viruses, thrown out of whack by Covid, appear to be falling back into seasonal order

Respiratory viruses, thrown out of whack by Covid, appe...

Nov 21, 2023

In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see

In absence of Roe v. Wade, an abortion doctor dwells on...

Jun 24, 2023